{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T05:54:29Z","timestamp":1788155669833,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"crossref","award":["RS-2024-00403047"],"award-info":[{"award-number":["RS-2024-00403047"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14967-3","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:57:03Z","timestamp":1767049023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Alternative splicing patterns in genetic subtypes of diffuse large B-cell lymphoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Sanyeowool","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junshik","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yeop","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja Min","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngil","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"9","key":"14967_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med. 2021;384(9):842\u201358.","journal-title":"N Engl J Med"},{"issue":"10","key":"14967_CR2","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.3324\/haematol.2024.285255","volume":"109","author":"M Melody","year":"2024","unstructured":"Melody M, Gordon LI. Sequencing of cellular therapy and bispecific antibodies for the management of diffuse large B-cell lymphoma. Haematologica. 2024;109(10):3138\u201345.","journal-title":"Haematologica"},{"issue":"6769","key":"14967_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503\u201311.","journal-title":"Nature"},{"issue":"4","key":"14967_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright GW, Huang DW, Phelan JD, Coulibaly ZA, Roulland S, Young RM, et al. A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell. 2020;37(4):551-568 e514.","journal-title":"Cancer Cell"},{"key":"14967_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2020.100728","volume":"53","author":"R Sciarrillo","year":"2020","unstructured":"Sciarrillo R, Wojtuszkiewicz A, Assaraf YG, Jansen G, Kaspers GJL, Giovannetti E, et al. The role of alternative splicing in cancer: from oncogenesis to drug resistance. Drug Resist Updat. 2020;53:100728.","journal-title":"Drug Resist Updat"},{"issue":"8","key":"14967_CR6","first-page":"2636","volume":"10","author":"R Zhang","year":"2018","unstructured":"Zhang R, Lin P, Yang X, He RQ, Wu HY, Dang YW, et al. Survival associated alternative splicing events in diffuse large B-cell lymphoma. Am J Transl Res. 2018;10(8):2636\u201347.","journal-title":"Am J Transl Res"},{"issue":"8","key":"14967_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.71","volume":"7","author":"SK Leivonen","year":"2017","unstructured":"Leivonen SK, Taskinen M, Cervera A, Karjalainen-Lindsberg ML, Delabie J, Holte H, et al. Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma. Blood Cancer J. 2017;7(8):e596.","journal-title":"Blood Cancer J"},{"issue":"728","key":"14967_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade2774","volume":"16","author":"EC Wheeler","year":"2024","unstructured":"Wheeler EC, Martin BJE, Doyle WC, Neaher S, Conway CA, Pitton CN, et al. Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML. Sci Transl Med. 2024;16(728):eade2774.","journal-title":"Sci Transl Med"},{"issue":"44","key":"14967_CR9","doi-asserted-by":"publisher","first-page":"77567","DOI":"10.18632\/oncotarget.20658","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Bhadra M, Sinnakannu JR, Yue WL, Tan CW, Rigo F, et al. Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides. Oncotarget. 2017;8(44):77567\u201385.","journal-title":"Oncotarget"},{"issue":"2","key":"14967_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","volume":"171","author":"A Reddy","year":"2017","unstructured":"Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, et al. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. Cell. 2017;171(2):481-494 e415.","journal-title":"Cell"},{"issue":"16","key":"14967_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"14967_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, et al. The ensembl variant effect predictor. Genome Biol. 2016;17(1):122.","journal-title":"Genome Biol"},{"issue":"1","key":"14967_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, et al. Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 2017;19(1):4\u201323.","journal-title":"J Mol Diagn"},{"issue":"3","key":"14967_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1101\/gr.257246.119","volume":"31","author":"S Uhrig","year":"2021","unstructured":"Uhrig S, Ellermann J, Walther T, Burkhardt P, Frohlich M, Hutter B, et al. Accurate and efficient detection of gene fusions from RNA sequencing data. Genome Res. 2021;31(3):448\u201360.","journal-title":"Genome Res"},{"issue":"1","key":"14967_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"key":"14967_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-1-0716-0301-7_11","volume":"2117","author":"G Yu","year":"2020","unstructured":"Yu G. Gene ontology semantic similarity analysis using GOSemSim. Methods Mol Biol. 2020;2117:207\u201315.","journal-title":"Methods Mol Biol"},{"issue":"4","key":"14967_CR17","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41596-023-00944-2","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Xie Z, Kutschera E, Adams JI, Kadash-Edmondson KE, Xing Y. rMATS-turbo: an efficient and flexible computational tool for alternative splicing analysis of large-scale RNA-seq data. Nat Protoc. 2024;19(4):1083\u2013104.","journal-title":"Nat Protoc"},{"key":"14967_CR18","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.8900.2","volume":"5","author":"M Nowicka","year":"2016","unstructured":"Nowicka M, Robinson MD. DRIMSeq: a Dirichlet-multinomial framework for multivariate count outcomes in genomics. F1000Res. 2016;5:1356.","journal-title":"F1000Res"},{"issue":"1","key":"14967_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.celrep.2018.01.088","volume":"23","author":"M Seiler","year":"2018","unstructured":"Seiler M, Peng S, Agrawal AA, Palacino J, Teng T, Zhu P, et al. Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types. Cell Rep. 2018;23(1):282-296 e284.","journal-title":"Cell Rep"},{"issue":"1","key":"14967_CR20","doi-asserted-by":"publisher","first-page":"30370","DOI":"10.1038\/s41598-024-81420-z","volume":"14","author":"M Xu","year":"2024","unstructured":"Xu M, Ruan M, Zhu W, Xu J, Lin L, Li W, et al. Integrative analysis of a novel immunogenic PANoptosis-related gene signature in diffuse large B-cell lymphoma for prognostication and therapeutic decision-making. Sci Rep. 2024;14(1):30370.","journal-title":"Sci Rep"},{"issue":"10","key":"14967_CR21","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1182\/blood-2016-10-692400","volume":"129","author":"B Saez","year":"2017","unstructured":"Saez B, Walter MJ, Graubert TA. Splicing factor gene mutations in hematologic malignancies. Blood. 2017;129(10):1260\u20139.","journal-title":"Blood"},{"issue":"5","key":"14967_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101306","volume":"297","author":"SR Kundinger","year":"2021","unstructured":"Kundinger SR, Dammer EB, Yin L, Hurst C, Shapley S, Ping L, et al. Phosphorylation regulates arginine-rich RNA-binding protein solubility and oligomerization. J Biol Chem. 2021;297(5):101306.","journal-title":"J Biol Chem"},{"issue":"22","key":"14967_CR23","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1182\/blood-2008-12-193037","volume":"113","author":"W Ci","year":"2009","unstructured":"Ci W, Polo JM, Cerchietti L, Shaknovich R, Wang L, Yang SN, et al. The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL. Blood. 2009;113(22):5536\u201348.","journal-title":"Blood"},{"issue":"2","key":"14967_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","volume":"13","author":"AL Shaffer","year":"2000","unstructured":"Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. Bcl-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity. 2000;13(2):199\u2013212.","journal-title":"Immunity"},{"issue":"23","key":"14967_CR25","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1182\/blood.2024024281","volume":"144","author":"Q Jin","year":"2024","unstructured":"Jin Q, Harris E, Myers JA, Mehmood R, Cotton A, Shirnekhi HK, et al. Disruption of cotranscriptional splicing suggests RBM39 is a therapeutic target in acute lymphoblastic leukemia. Blood. 2024;144(23):2417\u201331.","journal-title":"Blood"},{"issue":"1","key":"14967_CR26","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.1038\/s41467-023-40254-5","volume":"14","author":"S Campagne","year":"2023","unstructured":"Campagne S, Jutzi D, Malard F, Matoga M, Romane K, Feldmuller M, et al. Molecular basis of RNA-binding and autoregulation by the cancer-associated splicing factor RBM39. Nat Commun. 2023;14(1):5366.","journal-title":"Nat Commun"},{"issue":"3","key":"14967_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ccell.2019.02.013","volume":"35","author":"R Thomas","year":"2019","unstructured":"Thomas R, Majeti R. No matter how you splice it, RBM39 inhibition targets spliceosome mutant AML. Cancer Cell. 2019;35(3):337\u20139.","journal-title":"Cancer Cell"},{"issue":"1","key":"14967_CR28","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1038\/s41467-024-48615-4","volume":"15","author":"J Inamo","year":"2024","unstructured":"Inamo J, Suzuki A, Ueda MT, Yamaguchi K, Nishida H, Suzuki K, et al. Long-read sequencing for 29 immune cell subsets reveals disease-linked isoforms. Nat Commun. 2024;15(1):4285.","journal-title":"Nat Commun"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14967-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14967-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14967-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:57:03Z","timestamp":1767049023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-14967-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14967"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14967-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1910"}}